Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Tuesday, July 28, 2009

Polaris helps pump $6M into Egnyte

By Mass High Tech Staff

Waltham-based venture capital firm Polaris Venture Partners has jumped on board as a new investor in a $6 million funding in California company Egnyte Inc., a provider of on-demand file server products.

 The Series A round, which also saw participation from existing seed investor Maples Investments, will be used to speed market adoption of Egnyte’s products and grow the company’s channel distribution, according to officials.

Egnyte, founded in 2006, provides an On-Demand File Server for small and midsize businesses to store all corporate data, securely share files within and outside the company, and back up employee computers in the cloud. In March 2009, the company a blended online and on-premises product called Egnyte “Local Cloud.”

Polaris Venture Partners and Maples Investments are also investors in LogMeIn and SolarWinds, both of which went public in recent months.

In the last week, Polaris participated in funding rounds in hydrogel company I-Therapeutix Inc., protein-silencing drug maker Avila Therapeutics Inc. of Waltham, and Cerulean Pharma Inc. of Cambridge.
 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.